Cancer associated serum antigen (CASA) levels in patients with breast carcinoma and in 3 control groups without breast cancer

Archives of Gynecology and Obstetrics

Volumn 261, Issue 3, 1998, Pages 159-162

  Meisel, M ^a   Weise, J ^a   Schwesinger, G ^a   Straube, W ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Breast cancer; Tumor marker CASA

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MONOCLONAL ANTIBODY; MUCIN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CA-15-3 ANTIGEN; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REFERENCE VALUES; TUMOR MARKERS, BIOLOGICAL;

EID: 0031840567     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004040050215     Document Type: Article

References (10)

1. Bray KR, Koda JE, Gaur PK (1987) Serum levels and biochemical characteristics of cancer associated antigen CA 549, a circulating breast cancer marker. Cancer Res 47: 5853-5860
2. Colomer R, Ruibal A, Navarro M, Encabo G, Sole LA, Salvador L (1986) Circulating CA 15-3 levels in breast cancer. Our present experience. Int J Biol Markers 1:89-92
3. Devine PL, McGuckin MA, Ramm LE, Ward BG, Pee D, Long S (1993) Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon and prostate. Cancer 72:2007-2015
4. Gion M, Cappelli G, Mione R, Pistorello M, Meo S, Vignati G, Fortunato A, Saracchini S, Biasioli R, Giulisano M (1994) Evaluation of critical differences of CEA and CA 15-3 levels in serial samples from patients operated for breast cancer. Int J Biol Markers 9: 135-139
5. Jäger W, Krämer S, Palapelas V, Lang N (1995) Breast cancer and clinical utility of CA 15-3 and CEA. Scand J Clin Lab Invest 55: 87-92
6. Krämer S, Jäger W, Wildt L, Lang N (1996) CEA and CA 15-3 beim Mammakarzinom: Ihre Bedeutung für die Diagnose von Primärtumoren, Lokalrezidiven und Fernmetastasen. Geburtshilfe Frauenheilkd 56:618-624
7. Lamerz R (1980) Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer. Oncodev Biol Med 1: 123-135
8. Layton GT, Xing P-X, McKenzie IFC, Bishop JF, McGuckin MA (1991) Cancer-associated serum antigen (CASA) and ovarian serum antigen (OSA): two new tumor marker kits for detecting carcinoma-associated mucins. Tumor Marker Oncol 6:9-17
9. McGuckin MA, Layton GT, Bailey MJ, Hurst T, Khoo SK, Ward BG (1990) Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma - comparison with CA125. Gynecol Oncol 37: 165-171
10. McGuckin MA, Ramm LE, Joy GJ, Devine PL, Ward BG (1993) Circulating tumour associated mucin concentrations, determined by the CASA assay, in healthy women. Clin Chim Acta 214: 139-151